Stockchase Opinions

David BurrowsMedicis Pharmaceutical CorpMRXTOP PICKSep 13, 2006

Sector that has been out of favour and under owned for some time. Have had a tough 3/4 years and have been going through a restructuring. Starting to see some benefits. Kind of stock portfolio managers like to get into in a slowdown.
$31.29

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK
Uses Restolane in place of Botox. Demographically very attractive.